智通财经APP获悉，兆科眼科-B(06622)盘中涨超5%，截至发稿，涨5.71%，报2.96港元，成交额517.85万港元。
消息面上，据兆科眼科官微消息，7月15日，公司宣布最近与法国领先医药企业—FAREVA Group(“FAREVA”)达成战略合作。根据该备忘录，兆科眼科将成为FAREVA客户在中国寻求药品生产的值得信任的推荐合作伙伴。
兆科眼科董事会主席、执行董事兼行政总裁李小羿表示：“兆科眼科的研发能力和世界级的生产能力均获得海外合作伙伴的认可，进一步验证了我们的全球标准。开发药物要求在每一个阶段都追求卓越，特别是在研发和生产环节，这是将科学转化为现实的关键；我们位于中国广州南沙的先进生产基地正是这项承诺的有力体现。此外，这项战略伙伴关系，也标志着我们全球扩张战略再次迈出重要一步。“
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.